72 related articles for article (PubMed ID: 19574767)
1. High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
Hirst JE; Gard GB; McIllroy K; Nevell D; Field M
Int J Gynecol Cancer; 2009 Jul; 19(5):826-9. PubMed ID: 19574767
[TBL] [Abstract][Full Text] [Related]
2. Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.
Kang OJ; Lee SW; Kim JH; Park JY; Suh DS; Kim DY; Kim JH; Kim YM; Kim YT
Int J Gynecol Cancer; 2023 Nov; 33(11):1743-1749. PubMed ID: 37541685
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast and ovarian cancer triggered by occult fallopian tube cancer: a case report.
Murakami H; Fujiwara S; Nishie R; Ueda S; Terada S; Yamada T; Ohmichi M
J Med Case Rep; 2023 Aug; 17(1):351. PubMed ID: 37592269
[TBL] [Abstract][Full Text] [Related]
4. Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.
Gatius S; Matias Guiu X; Davidson B
Virchows Arch; 2024 Feb; 484(2):339-351. PubMed ID: 38099957
[TBL] [Abstract][Full Text] [Related]
5. Bilateral adrenal cortical rests: An interesting innocuous intruder in the fallopian tubes.
Gaffoor N; Shetty A; Vidhya V; Nikhil PV; Mysorekar V
Indian J Pathol Microbiol; 2024 May; ():. PubMed ID: 38727413
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.
Kalantari F; Schweighofer-Zwink G; Hecht S; Rendl G; Pirich C; Beheshti M
Rofo; 2024 Apr; ():. PubMed ID: 38626884
[No Abstract] [Full Text] [Related]
7. Recommendations for diagnosing STIC: a systematic review and meta-analysis.
Bogaerts JMA; Steenbeek MP; van Bommel MHD; Bulten J; van der Laak JAWM; de Hullu JA; Simons M
Virchows Arch; 2022 Apr; 480(4):725-737. PubMed ID: 34850262
[TBL] [Abstract][Full Text] [Related]
8. Cell Origins of High-Grade Serous Ovarian Cancer.
Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
[TBL] [Abstract][Full Text] [Related]
9. Screening for ovarian cancer: imaging challenges and opportunities for improvement.
Mathieu KB; Bedi DG; Thrower SL; Qayyum A; Bast RC
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):293-303. PubMed ID: 28639753
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and heterogeneity of ovarian cancer.
Kroeger PT; Drapkin R
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):26-34. PubMed ID: 27898521
[TBL] [Abstract][Full Text] [Related]
11. CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.
Kuhn E; Wang TL; Doberstein K; Bahadirli-Talbott A; Ayhan A; Sehdev AS; Drapkin R; Kurman RJ; Shih IeM
Mod Pathol; 2016 Oct; 29(10):1254-61. PubMed ID: 27443516
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention.
George SH; Garcia R; Slomovitz BM
Front Oncol; 2016; 6():108. PubMed ID: 27200296
[TBL] [Abstract][Full Text] [Related]
13. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.
Kurman RJ; Shih IeM
Am J Pathol; 2016 Apr; 186(4):733-47. PubMed ID: 27012190
[TBL] [Abstract][Full Text] [Related]
14. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.
Maritschnegg E; Wang Y; Pecha N; Horvat R; Van Nieuwenhuysen E; Vergote I; Heitz F; Sehouli J; Kinde I; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Speiser P; Zeillinger R
J Clin Oncol; 2015 Dec; 33(36):4293-300. PubMed ID: 26552420
[TBL] [Abstract][Full Text] [Related]
15. Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.
Kim SI; Lim MC; Lee DO; Kong SY; Seo SS; Kang S; Lee ES; Park SY
J Cancer Res Clin Oncol; 2016 Jan; 142(1):333-40. PubMed ID: 26438354
[TBL] [Abstract][Full Text] [Related]
16. Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
Sherman ME; Piedmonte M; Mai PL; Ioffe OB; Ronnett BM; Van Le L; Ivanov I; Bell MC; Blank SV; DiSilvestro P; Hamilton CA; Tewari KS; Wakeley K; Kauff ND; Yamada SD; Rodriguez G; Skates SJ; Alberts DS; Walker JL; Minasian L; Lu K; Greene MH
J Clin Oncol; 2014 Oct; 32(29):3275-83. PubMed ID: 25199754
[TBL] [Abstract][Full Text] [Related]
17. BRCA-associated ovarian cancer: from molecular genetics to risk management.
Girolimetti G; Perrone AM; Santini D; Barbieri E; Guerra F; Ferrari S; Zamagni C; De Iaco P; Gasparre G; Turchetti D
Biomed Res Int; 2014; 2014():787143. PubMed ID: 25136623
[TBL] [Abstract][Full Text] [Related]
18. BRCA and Early Events in the Development of Serous Ovarian Cancer.
George SH; Shaw P
Front Oncol; 2014; 4():5. PubMed ID: 24478985
[TBL] [Abstract][Full Text] [Related]
19. Identification of quiescent, stem-like cells in the distal female reproductive tract.
Wang Y; Sacchetti A; van Dijk MR; van der Zee M; van der Horst PH; Joosten R; Burger CW; Grootegoed JA; Blok LJ; Fodde R
PLoS One; 2012; 7(7):e40691. PubMed ID: 22848396
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.
Landon G; Stewart J; Deavers M; Lu K; Sneige N
Gynecol Oncol; 2012 Jun; 125(3):683-6. PubMed ID: 22425664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
